Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dichlorophen is a halogenated phenolic compound used primarily as an antimicrobial and antiparasitic agent. It exhibits activity against cestodes (tapeworms), protozoa, fungi, and bacteria. In veterinary medicine, it is often combined with toluene for the removal of intestinal parasites such as ascarids, hookworms, and tapeworms in dogs and cats. It has also been used in humans for the treatment of tapeworm infestations and as a topical antifungal agent (e.g., athlete’s foot). The mechanism of action involves disruption of cellular processes in microorganisms by uncoupling oxidative phosphorylation, thereby inhibiting energy production within cells[1][3][4][5][6]. Dichlorophen is also utilized as a fungicide and bactericide in cosmetics and for protecting materials from mold and algae[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dichlorophen.